Isagro sales down 8% in Q1 2019
May. 17, 2019
On a like-for-like basis, in 2019 Isagro expects a substantial consolidation of 2018 revenues from agropharma, with expectations of a significant growth in the mid-term thanks particularly to the new fungicide Fluindapyr. It is thus confirmed the objective of Isagro to achieve a turnover of 200 Euro million in the mid-term, also catching opportunities of external growth, with a better definition of its asset allocation.
More from AgroNews
Subscribe to daily email alerts of AgroNews.